Table 5.
Multivariate analysis of possible risk factors using the Cox logistic regression method.
Characteristics | Relapse-free survival | Overall survival | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | p value | |
Recurrent Stages | ||||
Advanced stage (rIVA/rIVB/rIVC) | 2.58 (1.47~4.54) | 0.001 | 3.92 (2.01~7.64) | < 0.001 |
Early stage (rI/rII/rIII) | 1.0 (reference) | 1.0 (reference) | ||
TILs Foxp3+ lymphocytes | ||||
High | 1.72 (0.96~3.05) | 0.07 | 1.30 (0.68~2.50) | 0.43 |
Low | 1.0 (reference) | 1.0 (reference) | ||
TILs CD8+ lymphocytes | ||||
Low | 2.40 (1.37~4.18) | 0.002 | 2.16 (1.14~4.08) | 0.02 |
High | 1.0 (reference) | 1.0 (reference) | ||
Recurrent NPC Galectin-9 expression | ||||
High | 1.72 (0.96~3.06) | 0.07 | 1.46 (0.78~2.73) | 0.23 |
Low | 1.0 (reference) | 1.0 (reference) |
Abbreviation: NPC, nasopharyngeal carcinoma; TILs, tumour-infiltrating lymphocytes, HR: hazard ratio.